Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modulation of the Left Prefrontal Cortex with High Frequency Repetitive Transcranial Magnetic Stimulation Facilitates Gait in Multiple Sclerosis.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States.
Exome and regulatory element sequencing of neuromyelitis optica patients.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
Evaluating individual change with the Quality of Life in Neurological Disorders (Neuro-QoL) Short Forms.
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis.
Estrogen regulates excitatory amino acid carrier 1 (EAAC1) expression through sphingosine kinase 1 (SphK1) transacting FGFR-mediated ERK signaling in rat C6 astroglial cells.
IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells.
Appendix: clinical evaluation and treatment of transverse myelitis.
Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells.
Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Internet-based home training is capable to improve balance in multiple sclerosis: a comparative trial with hippotherapy.
Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.
A simple procedure for the extraction of DNA from long-term formalin-preserved brain tissues for the detection of EBV by PCR.
Acquired Immunologic Neuropathies.
Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study.
Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods.
Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
MicroRNA-23a promotes myelination in the central nervous system.
Acute demyelinating encephalomyelitis presenting with psychiatric symptoms.
Pages
« first
‹ previous
…
666
667
668
669
670
671
672
673
674
…
next ›
last »